Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

41.52
+0.42001.02%
Post-market: 41.520.00000.00%19:30 EDT
Volume:1.12M
Turnover:46.61M
Market Cap:2.42B
PE:13.43
High:41.72
Open:41.30
Low:40.92
Close:41.10
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:1.04
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.42
PE(LYR):15.32

Loading ...

Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Feb 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 15, 2023

Correspondence

Form CORRESP - Correspondence